Position in AMGN
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$1,443,410
+$3,992 QoQ
Shares Held
3,986
-2.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#1,461
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Obermeyer Wealth Partners holds $14,931,348 across 9 Drug Manufacturers - General names. AMGN ranks #5 (9.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
12,201 | $3,098,687 | |
| 2 | ABBV |
AbbVie Inc.
|
10,832 | $2,725,764 | |
| 3 | AZN |
Astrazeneca PLC
|
11,635 | $2,206,228 | |
| 4 | LLY |
ELI LILLY & Co
|
1,757 | $2,107,398 | |
| 5 | AMGN |
Amgen Inc
This page
|
3,986 | $1,443,410 | |
| 6 | PFE |
Pfizer Inc
|
49,336 | $1,188,010 | |
| 7 | MRK |
Merck & Co., Inc.
|
8,359 | $1,074,131 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
12,532 | $722,093 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,443,410 | 3,986 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $1,439,418 | 4,091 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $1,384,193 | 4,229 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $1,241,962 | 4,401 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $1,298,605 | 4,651 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $1,411,009 | 4,529 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $1,117,884 | 4,289 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,363,592 | 4,232 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $1,293,230 | 4,139 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $1,161,447 | 4,085 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $1,177,137 | 4,087 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $1,053,001 | 3,918 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $624,542 | 2,813 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $706,635 | 2,923 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $777,151 | 2,959 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $666,958 | 2,959 | Shares | Sole | 2022-12-09 | |
| 2022-06-30 | $710,679 | 2,921 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $679,756 | 2,811 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $749,150 | 3,330 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $708,124 | 3,330 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $811,687 | 3,330 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $828,537 | 3,330 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $284,181 | 1,236 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $352,774 | 1,388 | Shares | Sole | 2020-10-22 | |
| 2020-06-30 | $398,131 | 1,688 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $353,966 | 1,746 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||